Table 3.
Univariate analyses | Coefficient | Multivariate analyses | |||||
---|---|---|---|---|---|---|---|
HR | 95% CI | P-value | HR | 95% CI | P-value | ||
Age (≥ 61 years vs. < 61 years) | 1.347 | 0.950–1.910 | 0.094 | ||||
Gender (male vs. female) | 0.817 | 0.573–1.164 | 0.264 | ||||
Grade (3–4 vs. 1–2) | 1.118 | 0.780–1.603 | 0.545 | ||||
AJCC PT (3–4 vs. 1–2) | 2.548 | 1.794–3.617 | < 0.001 | ||||
AJCC PN (1–2 vs. 0) | 1.516 | 1.052–2.185 | 0.026 | ||||
AJCC PM (1–2 vs. 0) | 1.674 | 1.162–2.413 | 0.006 | 0.803 | 2.231 | 1.269–3.924 | 0.005 |
AJCC stage (3–4 vs. 1–2) | 2.442 | 1.685–3.540 | < 0.001 | ||||
Child pugh (2–3 vs. 1) | 1.614 | 0.796–3.270 | 0.184 | ||||
Prognostic nomogram (high vs. low) | 4.162 | 2.798–6.191 | < 0.001 | 1.591 | 4.909 | 2.751–8.762 | < 0.001 |
AJCC The American Joint Committee on Cancer, HR hazard ratio, CI confidence interval